Challenges in the Global ADHD Medication Supply Chain
Attention-Deficit/Hyperactivity Disorder (ADHD) affects millions globally, primarily children and adolescents. Effective treatment for ADHD often involves stimulant medications (such as methylphenidate and amphetamines) and non-stimulants (like atomoxetine). However, the global supply chain for ADHD medications has faced significant challenges recently, leading to shortages in various regions. These disruptions affect individuals who rely on these medications